(BKUI) BNY Mellon Trust - BNY - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US09661T8595
BKUI: Fixed Income Securities, Short-Duration Debt, High-Quality Bonds
The BNY Mellon Ultra Short Income ETF (BKUI) is designed to provide investors with a low-risk, short-term investment solution by investing at least 80% of its net assets in high-quality, U.S. dollar-denominated debt securities and cash equivalents. The funds investment strategy focuses on maintaining a short effective duration, typically one year or less, to minimize exposure to interest rate fluctuations. However, during periods of significant market volatility, the duration may extend beyond one year. The portfolio is constructed to maintain an average credit rating of at least A or equivalent, ensuring a high level of credit quality.
Given the current market conditions and the funds characteristics, it is likely that BKUI will continue to attract investors seeking low-risk, short-term investment opportunities. The funds assets under management (AUM) stand at $213.41 million, indicating a moderate level of investor interest. With an average credit rating of at least A, the fund is well-positioned to navigate potential credit market turbulence.
Analyzing the technical data, the funds last price is $49.68, with a 20-day simple moving average (SMA) of $49.60 and a 50-day SMA of $49.49, indicating a stable short-term trend. The 200-day SMA is $48.76, suggesting a longer-term uptrend. The average true range (ATR) is $0.05, equivalent to 0.10%, indicating low volatility. Based on these technical indicators, it is likely that the fund will continue to trade within a narrow range in the short term.
Combining the technical and fundamental data, a forecast for BKUI is that it will maintain its stable performance in the short term, with a potential for slight appreciation given its low volatility and high credit quality. The funds short effective duration and high average credit rating position it well to navigate potential interest rate changes and credit market fluctuations. As such, it is likely to remain an attractive option for investors seeking low-risk, short-term investments. In the next 6-12 months, the price is expected to range between $49.50 and $50.50, with a potential target of $50.00.
Additional Sources for BKUI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
BKUI ETF Overview
Market Cap in USD | 231m |
Category | Ultrashort Bond |
TER | 0.12% |
IPO / Inception | 2021-08-09 |
BKUI ETF Ratings
Growth Rating | 66.1 |
Fundamental | - |
Dividend Rating | 73.5 |
Rel. Strength | 9.26 |
Analysts | - |
Fair Price Momentum | 52.45 USD |
Fair Price DCF | - |
BKUI Dividends
Dividend Yield 12m | 4.91% |
Yield on Cost 5y | 5.52% |
Annual Growth 5y | 120.64% |
Payout Consistency | 80.0% |
Payout Ratio | % |
BKUI Growth Ratios
Growth Correlation 3m | 97.7% |
Growth Correlation 12m | 99.9% |
Growth Correlation 5y | 91.7% |
CAGR 5y | 3.40% |
CAGR/Max DD 5y | 1.97 |
Sharpe Ratio 12m | 1.74 |
Alpha | 1.35 |
Beta | -0.007 |
Volatility | 0.51% |
Current Volume | 10.8k |
Average Volume 20d | 10.7k |
As of June 25, 2025, the stock is trading at USD 49.81 with a total of 10,815 shares traded.
Over the past week, the price has changed by +0.12%, over one month by +0.43%, over three months by +1.18% and over the past year by +5.49%.
Yes. Based on ValueRay´s Analyses, BNY Mellon Trust - BNY (NYSE ARCA:BKUI) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 66.08 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BKUI is around 52.45 USD . This means that BKUI is currently overvalued and has a potential downside of 5.3%.
BNY Mellon Trust - BNY has no consensus analysts rating.
According to our own proprietary Forecast Model, BKUI BNY Mellon Trust - BNY will be worth about 56.6 in June 2026. The stock is currently trading at 49.81. This means that the stock has a potential upside of +13.71%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 56.6 | 13.7% |